Point72 Asset Management, L.P. 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-15 10:35 am Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Point72 Asset Management, L.P. | 2,894,093 3.500% | -1,027,133 (-26.19%) | Filing |
| 2024-03-07 4:15 pm Purchase | 2024-03-06 | 13G | Terns Pharmaceuticals, Inc. TERN | Point72 Asset Management, L.P. | 3,921,226 6.300% | 3,921,226 (New Position) | Filing |